Published by Josh White on 24th October 2022
(Sharecast News) - Diagnostic monoclonal antibody specialist BioVentix reported a 7% improvement in revenue in its full-year results on Monday, to £11.72m.
URL: http://www.digitallook.com/dl/news/story/33055354/...